A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer

Journal:

European Urology

Published:

2026-03-14

DOI:

10.1016/j.eururo.2026.02.011

Affiliations:

10

Authors:

38

Go to article

Institutions	Authors	Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)	34.000000 34.000000 34.000000 34.000000	0.89
Fox Chase Cancer Center (FCCC), United States of America (USA)	1.000000	0.03
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.03
The University of British Columbia (UBC), Canada	1.000000	0.03
Louisiana State University (LSU), United States of America (USA)	1.000000	0.03

Interested in Oncology and Carcinogenesis?